$150,780,000

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

biotechactiveONGOING · MOD OF 2022 CONTRACT

WORK BEGAN2022-06-01·LATEST ACTION2026-04-28·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50122C00028_7505_-NONE-_-NONE-

Award description

CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Latest obligation on the CARB-X antibacterial accelerator program, which funds Boston University's research into new antibiotics since 2022.

Sub-sectors

antibiotic-developmentpandemic-preparednessacademic-research

Why this matters

Antibiotic resistance is a critical public health threat; CARB-X accelerates development of novel antibiotics to counter drug-resistant bacteria.

Supply-chain signal

Supports academic biotech pipeline for pharmaceutical manufacturing; strengthens domestic antibiotic innovation capacity.

U.S.–China competition angle

U.S. antibiotic development lags China in some classes; this investment shores up American pharmaceutical independence and biosecurity.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-24. Cost: $0.002969.

Period of performance

Start

2022-06-01

End

2029-05-31

Status

activein 1065 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50122C00028_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.